Actively Recruiting
Definitive Radiotherapy for Cervical and Upper Thoracic Esophageal Cancer (ChC&UES): A Multi-center Real World Study
Led by Hebei Medical University Fourth Hospital · Updated on 2024-07-01
2600
Participants Needed
1
Research Sites
1300 weeks
Total Duration
On this page
Sponsors
H
Hebei Medical University Fourth Hospital
Lead Sponsor
T
Tianjin Medical University Cancer Institute and Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Cervical and upper thoracic esophageal cancer (ESCA) presents treatment challenges due to limited clinical evidence. This multi-center study (ChC\&UES) explores radical radio(chemo)therapy efficacy and safety
CONDITIONS
Official Title
Definitive Radiotherapy for Cervical and Upper Thoracic Esophageal Cancer (ChC&UES): A Multi-center Real World Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 and older
- Confirmed esophageal cancer by histopathology or cytology
- Primary tumor located in cervical or upper thoracic esophagus
- No distant metastasis
- Unable or unwilling to have surgical treatment
- Receiving radical radiotherapy as first-line treatment with or without chemotherapy, immunotherapy, or targeted therapy
- Undergoing conventional radiotherapy (1.8-2.0Gy per session, once daily)
- Receiving 3DCRT or IMRT radiotherapy
- Complete radiotherapy dose information and follow-up records available
You will not qualify if you...
- Radiation dose below 50Gy
- History of other malignancies except cured cancer in situ or malignancies cured for more than 5 years
- Laryngeal invasion
- Diagnosis of double primary esophageal cancer
- Chest radiation therapy within the past 5 years
- Recurrent or metastatic esophageal cancer
- Use of 2D radiotherapy, large fractionation, or hyper-fractionation radiotherapy
- Incomplete radiotherapy dose or follow-up data
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Because this study is a response to real-world patient treatment and outcomes
Shijiazhuang, Hebei, China, 050000
Actively Recruiting
Research Team
W
Wenbin Shen
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here